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Introduction: United Nations sustainable development goals aim for the elimination of
viral hepatitis as a public health threat by 2030, leading to efforts to upscale the availability
and accessibility of hepatitis B virus (HBV) vaccination, diagnosis, and treatment globally.
However, a variety of societal factors, including beliefs, traditions, and stigma, can be a
major obstacle to all of these interventions. We therefore set out to investigate how HBV
is understood and described in communities in Uganda, and whether there is evidence
of potential stigma.
Method: We carried out a qualitative formative study in two sites in South Western
Uganda: a village in Kalungu district (site A) and an area on the outskirts of Masaka
town (site B). We undertook a rapid assessment to investigate how adults describe HBV
infection and their perceptions about the infection. We collected data by conducting
a transect walk, observations, community group discussions, and in-depth interviews,
sampling a total of 131 individuals. We used inductive content analysis to extract key
themes associated with HBV.
Results: There is no specific word for HBV infection in local languages, and knowledge
about this infection is varied. While some individuals were completely unfamiliar with HBV
infection, some had heard of HBV. Radio was a common source of information. There
was awareness of HBV as a cause of liver disease, but limited knowledge regarding
the cause, mode of transmission, and treatment. Stigma in HBV may be rare in this
community due to limited understanding and experience of HBV.
Conclusion: There is an ongoing need to improve awareness and understanding of HBV
in this community. Careful dissemination of accurate information is required to promote
acceptance of interventions for prevention, diagnosis, and treatment.
Keywords: stigma, hepatitis, infection, Uganda, Africa, HBV
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INTRODUCTION
Globally, ∼290 million people are chronically infected with
hepatitis B virus (HBV), and more than 800,000 people
consequently die each year from liver cirrhosis or liver cancer
(1). In response to the United Nations Sustainable Development
Goals, which aim to eliminate viral hepatitis as a public health
threat by the year 2030 (2), HBV infection is receiving increasing
recognition with efforts to upscale prevention, diagnosis, and
treatment (1, 3). However, there are complex barriers to
the elimination of this infection in the African subcontinent,
including a high prevalence of chronic infection (≥8% in many
settings), >90% of those infected being undiagnosed, and poor
awareness (4, 5).
Stigma and discrimination are recognized in the setting
of chronic viral hepatitis infections, but there is very limited
research to determine the nature and impact of stigma in
communities in Africa (4). To date, only three studies have
been carried out in Africa exploring the social impact of HBV.
In Zambia, stigma has been reported to be a barrier to HBV
disclosure and referral of contacts for testing (6), whereas in
Ghana, low levels of knowledge and pervasive misconceptions
about HBV contribute toward psychological and social problems
among individuals with chronic infection (7, 8). There has been
no previous work on stigma in HBV in Uganda, although HBV is
highly endemic in some regions [prevalence estimates vary from
6 to 52% (9–11)].
Given the high prevalence of HBV in Uganda, and the
emerging evidence of stigma in HBV, we sought to investigate
how adults in rural and peri-urban communities in Uganda
describeHBV infection, their perceptions, beliefs and experiences
about the infection, and whether there is evidence of stigma.
METHODS
Study Setting
We conducted the study at two sites in South West Uganda:
i. Site A: This is a village location within the General Population
Cohort (GPC). The GPC was established in a rural population
in south-western Uganda in Kyamulibwa sub-county of
Kalungu district in 1989, with the initial aim of studying
the epidemiology of HIV/AIDS in a rural population,
but subsequently also being a source of recruitment for
other research studies (12, 13). The GPC comprises 25
study villages with a total population of ∼25,000 people.
Most of the inhabitants practice small-scale farming. Local
tribes are Baganda, Banyarwanda, Barundi, and Banyakole.
A number of infectious diseases are prevalent, including
HIV (prevalence ∼10%), malaria, hepatitis B and C (HBV
prevalence 3%; HCV prevalence <1%), sexually transmitted
infections, and respiratory tract infections. Within this sub-
county, there are a number of public and private health care
Abbreviations: AIDS, Acquired Immunodeficiency Syndrome; GPC,
general population cohort, Uganda; HBV, hepatitis B virus; HIV, human
immunodeficiency virus; sSA, sub Saharan Africa; UK MRC, United Kingdom
Medical Research Council; WHO, World Health Organization.
facilities and traditional healers. We selected Site A for this
study because a previous survey on HBV reported a higher
prevalence within this village compared to elsewhere in the
GPC (unpublished data).
ii. Site B: This is a peri-urban site in Masaka Municipality,
located along the highway that connects Uganda to the
Democratic Republic of Congo, Tanzania and Rwanda, with
a high concentration of low-cost housing. Most of the
inhabitants earn their living from small businesses including
motorcycle transport, selling food, and running bars; crop
farming is also undertaken locally. The tribes represented in
this region are Baganda, Banyarwanda, Batoro, and Basoga.
The HIV prevalence in this setting may be slightly higher
than within the GPC, but accurate data are not available. The
prevalence of viral hepatitis infection is also not known but is
likely to be higher than the GPC, given the concentration of
settlements in the area and many inhabitants from different
areas of Uganda. There are several private and public health
care facilities in this site.
Study Design
Between July and October 2018, we conducted a rapid qualitative
assessment to investigate how HBV is described, the experiences
and beliefs associated with HBV, and the nature of any
associated stigma. These rapid methods included transect walks,
observations, introductory group sessions, community group
discussions, and in-depth interviews (Table 1), with the intention
that the different methods complemented each other. Fieldwork
was conducted at Site A first, after which the field team
moved to Site B.
Study Participants
Participants were recruited from the two sites using purposive
sampling in an approach designed to collect qualitative data
(14, 15). We selected individuals who were influential people
within the community such as community leaders, religious
leaders, health care providers, traditional healers, village health
teams. We also included people who had disclosed that they were
living with hepatitis B virus infection. We set out to include
participants representing both genders across a range of ages,
stratifying as male or female, and younger (18–30 years) vs. older
(>30 years). We recruited 131 people who met the above criteria.
We had no refusals; all participants who were contacted at all
stages of the study agreed to participate.
Data Collection
Data collection was done by two social science research assistants
who have an understanding of these communities and are fluent
in Luganda, the local language commonly used within the study
setting. The research assistants were first trained on all aspects of
the study and the use of a rapid qualitative assessment approach
(16). Before visits to the study communities, the research team
met with local leaders and explained the purpose of the study and
sought permission to enter these communities. All the data were
recorded using field notes that were expanded immediately after
data collection.
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TABLE 1 | Description of study areas and characteristics of study participants.
Method of data collection Data collected at Site A Data collected at Site B
Demographics of study
participants
Total number of participants: 67 (100%)
Male: 31 (46%)
Female: 36 (54%)
Median (min—max) age range: 26 (18–70) years
Total number of participants: 64 (100%)
Male: 30 (46%)
Female: 34 (54%)
Median (min—max) age range: 26 (18–70) years
Nature of regions sampled by
transect spiral walk
Approximate population size: 700 people
Main economic activity: Farming/trading
Health facilities: No health facility. Healthcare services sought
from neighboring villages.
Healthcare providers: Retired midwife, VHTs, Traditional Healer
Approximate population size: 2,000 people
Main economic activity: Trading
Health facilities: A medical center, pharmacies/drug stores
Healthcare providers: Clinical Officers, Nurses, VHTs, Traditional
Healers, Herbalists
Observations collected from
transect spiral walk
Comments recorded from five individuals including traditional
healers.
Comments recorded from four individuals, including healthcare
workers, and herbal medicine seller.
Participants represented in
introductory group session
Community leaders
Males (n = 6, aged 35–76)
Females (n = 5, aged 59–71)
Community leaders
Males (n = 5, aged 42–50)
Females (n = 5, aged 37–45)
Participants represented in
community group discussions
Young females (n = 10, aged 18–30)
Older females (n = 12, aged 35–70)
Young males (n = 9, aged 20–30)
Older males (n = 9, aged 40–70).
Young females (n = 10, aged 20–35)
Older females (n = 11, aged 35–70)
Young males (n = 11, aged 18–30),
Older males (n = 10, aged 35–55).
Participants represented through
in-depth individual interviews
Males (n = 5, aged 30–50)
Females (n = 6, aged 20–50)
Males (n = 3, aged 20–50)
Females (n = 5, aged 20–40)
VHT, village health team.
i. Transect spiral walk: The aim was to observe, discuss,
and find key features in the community that would inform
our other methodologies such as identifying settlement
patterns, health centers, churches, mosques, traditional
healers, trading centers, bars, and any other places where
people within communities concentrate. The transect walk
was performed to understand the daily activities of people
within the community in order to plan for the other
assessmentmethods effectively. Twomembers of the research
team first visited the local leader of each study site and
explained the reasons of the activity within this community.
With the help of the local leader, the team identified the
center of each village that was used as a starting point. The
team then split into two with each person taking a different
direction. They moved in concentric circles until the whole
village was covered. During the walk, observations were
made in addition to talking to a few people.
ii. Observations: Informed by the transect walk, we visited
particular places of interest to make observations. The team
engaged with members of the community and healthcare
providers [including traditional healers and village health
teams (VHTs)], with the aim of better understanding the
characteristics of individuals seeking health care, how and
where they are treated, common illnesses, familiarity with
HBV including local terms to describe it, its signs and
symptoms, and any personal experience of individuals with
HBV infection.
iii. Introductory group sessions: We met with ten influential
people within each community including community leaders
and local religious leaders, who had been identified based
on information collected during the transect walks. The
aim of these sessions was to understand perceptions and
beliefs of diseases and illnesses in the community, and to
explore understanding and experiences of HBV infection.
The sessions were moderated by one interviewer, while the
other was observing and taking notes.
iv. Community group discussions: We facilitated group
discussions among adults to find out about perceptions
and beliefs of disease within the community, specifically
exploring understanding, and experiences of HBV infection.
Four discussions were held at each study site with 10
participants in each group. These participants were identified
after the first three visits within the study communities.
v. In-depth individual interviews: We interviewed a selected
group of individuals who were willing to give information
about their experiences, to allow deeper exploration of
relevant issues established from the previous stages.
Data Management and Analysis
Researchers involved with data collection provided detailed
descriptions of their observations and interviews in accounts
written up from the notes. Two other researchers reviewed the
transcripts prior to analysis to check the quality and accuracy,
and thereafter independently coded the transcripts. We used
thematic content analysis: classifying our data into themes and
sub-themes relating to perceptions, beliefs, and experiences of
HBV and the description and nature of associated stigma, based
on narrative content, and research questions. Quotes used in the
article are words of the interviewee used in the accounts.
Ethical Approvals
Approval was provided by Research Ethics Committee of the
Uganda Virus Research Institute (ethics no GC/127/18/05/645)
and UK Oxford Tropical Ethics Committee, OxTREC (ethics
No. 516-18). All participants provided written informed consent
for interviews and discussion groups. The local leaders provided
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verbal consent for the transect walks within their communities
while health care providers, including traditional healers,
consented for observations.
RESULTS
Study Participants
Between September and December 2018, we collected data
from a total of 131 participants across Sites A and B.
Table 1 summarizes the description of study areas and socio-
demographic characteristics of study participants.
Knowledge and Awareness of HBV
Infection
Awareness of HBV infection in these communities was varied.
The commonest means of acquiring knowledge on HBV
infection was through radio advertisements which encouraged
members of the community to get tested and immunized
(reported by 31 participants, age range 18–70 years). Others
had personal experience of knowing someone perceived to be
infected or diagnosed with HBV (reported by 30 individuals,
age range 18–70 years). Among these respondents, 20 reported
the death of individuals perceived to have HBV infection shortly
after admission to a healthcare facility or as soon as they became
symptomatic. One personal experience was reported by a teacher
from site B: “A neighbor who had gone to work at the lake shore
came back when he was already infected. He was referred to a
hospital in Kampala but died after 2 days.”
There were 10 participants (age range 19–55 years) who
reported not having heard of HBV infection and therefore felt
that it may not be a common illness, including both males and
females from both settings. There is no specific name for HBV
infection; naming of a disease in this community commonly
depends on the symptoms of the disease. The local phrases
used to describe liver disease are “Obulwadde bwekibumba” and
“endwadde y’ekibumba” which literally translate to “the liver
is sick.”
Insights Into HBV as a Cause of Liver
Disease
As the symptoms and signs of HBV are not distinct from
other causes of liver disease, there may be poor understanding
of the role of an infectious agent. This is illustrated from a
comment recorded from the community group discussions at site
A, “We do not know about its mode of transmission, signs and
causes so we cannot tell if the disease exists in the community.”
Three participants specifically reported that they are not able to
distinguish HBV from other illnesses.
More generally, some participants were able to list other
causes of liver disease including excessive consumption of
alcohol and eating fatty foods. Insect bites, exposure to
pesticides/fertilizers and drinking dirty water were also suggested
as causes of liver disease. For example, a man at Site B
commented that: “it could be caused through excessive drinking
of waragi [local gin].... myrrh, khat drugs, herbal medicine, and
fertilizers/pesticides can affect and make the liver sick,” while
a woman of a similar age in Site A suggested that it was
caused by “walking through dirty swamp water which contains
certain germs that cause liver disease.” Some of the symptoms
that participants reported in association with HBV (or more
generally with liver disease) included abdominal or whole body
swelling, jaundice/yellow eyes, weight loss, and hair loss. Three
participants mentioned that HBV was asymptomatic. Thirteen
participants, mainly from Site A, were not able to suggest any
signs or symptoms associated with HBV. Eight participants
(aged 18–60 years) reported a similarity in signs and symptoms
between HIV and HBV.
Perceptions of Mode of Transmission
A number of participants, predominantly from Site B, reported
that they did not know how HBV is transmitted. Three people
believed that transmission routes included sharing of public
toilets/bathrooms, or sharing of utensils and clothing. A male at
site B stated: “When he shares any equipment—say clothing, cups,
and forks with a person who looked malnourished—he would feel
as if he was to contract the infection from him/her, not good to
share anything with the patient.”
Of the eight healthcare professionals who took part in this
study, only five knew that HBV is sexually transmitted and can
also be transmitted through other exposures to infected body
fluids. Five participants from Site A reported that anyone was at
risk of contracting HBV. People who consumed alcohol or those
who engage in risky sexual behaviors were considered to be at
risk of contracting HBV infection. One participant interpreted
the high-profile campaigns aroundHBV immunization for adults
as suggesting that only adults were susceptible to infection.
Knowledge of, and Access to, HBV
Treatment
Community members suggested possible management
interventions, including modified diet and herbal medicine.
Twelve participants, mostly from Site A (age range 18–70
years), did not know any treatment for HBV. Three young men
from Site B reported that HBV has no cure. Others correctly
recognized that antiretroviral drugs can be used in managing
HBV infection, and that those infected are put-on long-term
treatment, but some of the comments suggested that there is
pessimism about outcomes, with participants suggesting poor
chances of survival.
Potential Challenges Facing HBV
Management
The asymptomatic nature of HBV can be a barrier to seeking
healthcare services; some community members only seek
treatment when the symptoms are noticeable and have worsened,
and it may be common to stop taking medication in the absence
of symptoms. Poverty, preference for traditional/herbal medicine
and lack of awareness about a disease, can also contribute
to delays in seeking healthcare and be barriers to seeking
preventive, diagnostic and treatment services among members of
the community. A description of a child unwell as a result of HBV
infection was provided by a male participant at Site A: “When
the boy fell sick, he was taken to the health center for treatment.
He was not admitted but they gave him some tablets which he
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didn’t understand. He took the tablets and after a week the stomach
normalized. About 3 weeks later, the stomach resumed swelling.
He was taken to herbal clinic and was given 5 liters of herbal
medicine and he was told to go back after one week. When the
herbal was finished, he went back and still he was given the same
drugs. By that time his eyes had a yellowish color, his urine was
also yellow.”
Lack of diagnostic facilities, and limited access to healthcare
professionals and medications contribute to the challenges facing
HBV prevention, diagnosis, and therapy in this community. A
female healthcare worker at site A explained: “She can’t even give
that patient any drug, only refers him or her to Masaka hospital.
She said that they don’t have the machines that can diagnose it,
so they have to refer the patient.” Among healthcare workers,
poor knowledge can impede diagnosis and treatment for HBV
infection. Three healthcare professionals reported not having
received a complete course of HBV vaccination themselves and
are therefore at increased risk of becoming infected.
Community Perceptions and Experience of
HBV
We sought to understand the perception of community members
about the occurrence and persistence of HBV infection in their
community. Eleven participants, mostly from Site B reported that
HBV was a new infection in their community because they had
become aware of it only recently. For ten people who commented
that HBV was a long-standing problem, their knowledge came
from a community member known to them whom they believed
had died of the infection. Others claimed that HBV was
“an old sickness” which had been in the communities for a
long time.
Emotional Responses to HBV Infection
Communities tend to fear diseases based on symptoms and
outcomes associated with the disease. In particular, a disease
can be feared because it is incurable and may be seen
as leading inevitably to death (4). Stigma may stem from
this fear, as well as from changes in body appearance that
can limit interactions with other community members. Eight
participants, primarily from Site B, reported that they would
be scared or more cautious to take care of someone with
an infectious disease. Ten participants, mostly men from Site
B (age 18–50 years), reported a feeling of shame associated
with sexually transmitted diseases. However, eleven participants,
reported no fear or shame toward people infected with HBV,
partly because it is a disease that is not well-known within
the community.
DISCUSSION
With the recent increased attention regarding the urgent need to
upscale prevention, diagnosis, and treatment of HBV infection
globally, understanding the social impact of HBV infection in
communities is important as this influences acceptability and
impact of interventions. To date, there is very limited research
on behavior and beliefs surrounding HBV infection in Africa.
Familiarity with HBV infection in the communities we
investigated can be explained, in part, by the recent efforts by
the Ministry of Health in Uganda to combat transmission of
HBV by promoting vaccination among adolescents and young
adults (17), particularly using radio messages to reach a wide
audience. As a result, the syndrome of HBV infection is now
recognized by many adults in this setting. However, even among
healthcare workers, there is still a lack of in-depth understanding,
in keeping with similar studies in Ghana and Zambia (4, 6–8).
The importance of education is highlighted by a study of HBV
infection undertaken in Turkey (18).
Naming of a disease can be a reflection of how much it is
recognized and understood (19, 20). In our study population,
local names used to describe diseases are based on the symptoms
the sufferer bears. In part, this practice is encouraged by
the WHO which states that a name of a disease should be
based on the “symptoms, disease manifestation, severity and,
if known, the pathogen causing the disease” (21). Naming
HBV infection poses a challenge, since there is no specific
symptom that distinguishes it from other liver diseases, and
in many instances, it remains asymptomatic until the end-
stages of infection. Although we identified local terms that
broadly describe liver disease, gaps remain in understanding
of HBV infection, particularly with regard to the infectious
agent (21).
Stigma
As a result of limited understanding and experience of HBV
in our study population, stigma did not emerge as a strong
theme. However, fear of symptoms and outcomes of a disease,
as well as shame associated with mode of transmission of
infection, can determine how those infected might be handled
within their communities (22, 23), and can lead on to stigma.
Although sex is not the main route of transmission of HBV
infection, this association could nevertheless lead to stigma and
discrimination (24). Although HBV is asymptomatic in most
cases, acute infection or advanced stages of the disease could
result in visible manifestations, leading to isolation and lack of
support from community members. Careful dissemination of
accurate information on HBV is required to prevent possible
stigma and misperceptions of personal risk.
Studies fromAsia have reported stigma and limited knowledge
among health practitioners as obstacles in the uptake of
preventive, diagnostic, and treatment services among HBV
patients (4, 25). Delayed health seeking behavior has been widely
reported in tuberculosis and is a result of several factors such
as lack of symptoms, low patient knowledge, practicing self-
medication, and the use of traditional healing methods (26–28).
In our study, the asymptomatic nature of HBV, poverty and
lack of knowledge (including among healthcare workers) were
challenges in accessing timely and appropriate healthcare (29).
While there are efforts to improve knowledge on HBV among
healthcare professionals and community members in Uganda,
studies are needed to evaluate the evidence of effectiveness of
these interventions, and to evaluate availability, accessibility, and
integration of HBV services.
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Strength and Limitations of This Study
This is the first study to explore beliefs, understanding
and stigma around HBV infection in Uganda. A strength
of the study was that we sampled participants from both
urban and rural settings, sampling men and women, and
including a diverse range of ages which afforded a comparison
for HBV description, experiences, and understanding. This
approach provides some valuable reflections and insights into
local understanding and beliefs about HBV infection, but
represents only a small number of adults, who self-selected
to participate.
CONCLUSIONS
Engaging local communities, understanding barriers, and
providing appropriate and accessible information will be a crucial
undertaking if diagnosis, treatment, and preventive strategies
are to be rolled out to support progress toward the 2030
sustainable development goal targets for elimination of HBV
infection as a public health threat. Although radio campaigns
have raised some local awareness of HBV in the communities we
studied in Uganda, there remain significant gaps in knowledge
and understanding, and a risk of stigma associated with fear,
especially in the context of physical signs of liver disease.
Educating traditional healers and healthcare workers could
have a positive impact on disseminating information. Further
studies are needed to investigate the societal responses to HBV
infection in other African populations, and to establish the
best ways to engage with local populations to promote access
to interventions.
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